S256: TABELECLEUCEL FOR EBV-DRIVEN POST-TRANSPLANT LYMPHOPROLIFERATIVE DISEASE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL OR SOLID ORGAN TRANSPLANT AFTER FAILURE OF RITUXIMAB ± CHEMOTHERAPY (ALLELE). (23rd June 2022) - Prockop, S.; Beitinjaneh, A.; Choquet, S.; Dahiya, S.; Dinavahi, R.; Farah, R.; Gamelin, L.; Ghobadi, A.; Mehta, A.; Nayak, P.; Reshef, R.; Satyanarayana, G.; et al.